The board of directors of Nasdaq-listed Anixa Biosciences has approved the purchase of bitcoin as a reserve asset
2024-11-23 06:06:37
NASDAQ city company anixa biosciences board of directors approval purchase bitcoindesk3cryptocurrencydesktopCrypto News
The board of directors of Nasdaq-listed Anixa Biosciences has approved the purchase of bitcoin as a reserve asset. The company also reaffirmed its ongoing share buyback program. CEO Amit Kumar said the decision on bitcoin is another approach to prudent financial management that can achieve higher shareholder value. It is reported that Anixa Biosciences is a biotechnology company focused on the treatment and prevention of cancer.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
纳斯达克上市公司Anixa Biosciences董事会批准购买比特币作为储备资产Next article：
LM Funding公布新一期财报披露持有140.5枚BTC，价值1330万美元
